Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 4, 2000, Pages 349-357

  Streif, W ^a,b   Paes, B ^a   Berry, L ^a,c   Andrew, M ^a,b   Andreasen, R B ^d   Chan, A K C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d Hospital for Sick Children ^*

Author keywords

Factor VIIa; Newborn; Pre term; Thrombin; Tissue factor

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN;

ARTICLE; BLEEDING DISORDER; CONTROLLED STUDY; DRUG INDICATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NEWBORN; PREMATURITY; PRIORITY JOURNAL; THROMBIN TIME; UMBILICAL CORD BLOOD;

ADULT; FACTOR VIIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; THROMBIN; TIME FACTORS;

EID: 0034043075     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200006000-00006     Document Type: Article

References (30)

1. 1. Nemerson Y. The tissue factor pathway of blood coagulation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (editors): Hemostasis and thrombosis, basic principles and clinical practice. Philadelphia, PA: J.B. Lippincott; 1994. pp. 81-93.
2. 2. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coag Fibrinol 1998; 9(suppl 1): S147-S152.
3. 3. Kliegman RM. Birth injury. In: Behrman RE, Kliegman RM, Arvin AM (editors): Nelson, textbook of pediatrics. Philadelphia, PA: W.B. Saunders; 1996. pp. 465-471.
4. 4. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-624.
5. 5. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63: 27-30.
6. 6. Shah JK, Mitchell LG, Paes B, Ofosu FA, Schmidt B, Andrew M. Thrombin inhibition is impaired in plasma of sick neonates. Pediatr Res 1992; 31: 391-395.
7. 7. Massicotte P, Leaker M, Marzinotto V, Adams M, Freedom R, Williams W et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb Haemost 1998; 80: 570-574.
8. 8. Berry L, Andrew M, Post M, Ofosu F, O'Brodovich H. A549 lung epithelial cells synthesize anticoagulant molecules on the cell surface and matrix and in conditioned media. Am J Respir Cell Mol Biol 1991; 4: 338-346.
9. 9. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
10. 10. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172.
11. 11. Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, et al. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. Haemophilia. 1998; 4: 790-798.
12. 12. Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors. Am J Hematol 1994; 47: 36-40.
13. 13. Ingerslev J, Kristensen HL. Clinical picture and treatment strategies in factor VII deficiency. Haemophilia 1998; 4: 689-696.
14. 14. Hardy P, Varma DR, Chemtob S. Control of cerebral and ocular blood flow autoregulation in neonates. Pediatr Clin North Am 1997; 44: 137-152.
15. 15. Beverley DW, Pitts-Tucker TJ, Congdon PJ, Arthur RJ, Tate G. Prevention of intraventricular haemorrhage by fresh frozen plasma. Arch Dis Child 1985; 60: 710-713.
16. 16. Hambleton G, Appleyard WJ. Controlled trial of fresh frozen plasma in asphyxiated low birthweight infants. Arch Dis Child 1973; 48: 31-35.
17. 17. Waltl H, Fodisch HJ, Kurz R, Hohenauer L, Mitterstieler G, Rossler H. Intracranial haemorrhage in low-birth-weight infants and prophylactic administration of coagulation-factor concentrate. Lancet 1973; 1: 1284-1286.
18. 18. Shirahata A, Nakamura T, Shimono M, Kaneko M, Tanaka S. Blood coagulation findings and the efficacy of factor XIII concentrate in premature infants with intracranial hemorrhages. Thromb Res 1990; 57: 755-763.
19. 19. Thorp JA, Ferrette-Smith D, Gaston LA, Johnson J, Yeast JD, Meyer B. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation. Obstet Gynecol 1995; 86: 1-8.
20. 20. Turner T, Prowse CV, Prescott RJ, Cash JD. A clinical trial on the early detection and correction of haemostatic defects in selected high-risk neonates. Br J Haematol 1981; 47: 65-75.
21. 21. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123: 285-291.
22. 22. Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158: 470-476.
23. 23. Hoffmann M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coag Fibrinol 1998; 9: S61-S65.
24. 24. Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost 1999; 81: 245-249.
25. 25. Aronis S, Platokouki H, Photopoulos S, Adamtziki E, Xanthou M. Indications of coagulation and/or fibrinolytic system activation in healthy and sick very-low-birth-weight neonates. Biol Neonate 1998; 74: 337-344.
26. 26. Gerbasi FR, Bottoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol 1990; 162: 1158-1163.
27. 27. Knofler R, Hofmann S, Weissbach G, Kujlisch E, Neef B, Otte M, et al. Molecular markers of the endothelium, the coagulation and the fibrinolytic systems in healthy newborns. Semin Thromb Hemost 1998; 24: 453-461.
28. 28. Nako Y, Ohki Y, Harigaya A, Tomomasa T, Morikawa A. Plasma thrombomodulin level in very low birthweight infants at birth. Acta Paediatr 1997; 86: 1105-1109.
29. 29. Schmidt B, Mitchell L, Ofosu FA, Andrew M. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 1989; 62: 1074-1077.
30. 30. Delorme MA, Burrows RF, Ofosu FA, Andrew M. Thrombin regulation in mother and fetus during pregnancy. Semin Thromb Hemost 1992; 18: 81-90.